Theratechnologies (TH) Sets New 12-Month Low at $8.03
Shares of Theratechnologies Inc (TSE:TH) hit a new 52-week low on Wednesday . The stock traded as low as C$8.03 and last traded at C$7.98, with a volume of 159387 shares traded. The stock had previously closed at C$8.39.
Several brokerages recently weighed in on TH. Royal Bank of Canada restated a “sector perform” rating and set a C$11.00 price objective on shares of Theratechnologies in a research report on Tuesday, September 4th. Canaccord Genuity upped their price objective on Theratechnologies from C$13.00 to C$14.50 in a research report on Friday, July 6th. Finally, National Bank Financial restated an “outperform” rating and set a C$14.25 price objective on shares of Theratechnologies in a research report on Wednesday, June 20th.
About Theratechnologies (TSE:TH)
Theratechnologies Inc, a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. The company's lead product is EGRIFTA, which increases the incidence or progression of diabetic retinopathy in diabetic HIV-infected patients with lipodystrophy and excess abdominal fat in the United States and Canada.
Further Reading: Rule of 72
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.